This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Chemist Warehouse-Sigma Healthcare deal sparks public inquiry by Australian watchdog

By James Panichi ( March 8, 2024, 02:05 GMT | Insight) -- The owner of Australian pharmacy-franchise giant Chemist Warehouse is facing a public regulatory review of its plans to acquire the publicly listed Sigma Healthcare as part of a complex reverse acquisition that will see the two companies merge in a $463.6 million deal. the Australian Competition & Consumer Commission appears set to focus on how the deal providing Chemist Warehouse owner CW Group with a fast-track route to the stock market will affect the wholesale and distribution of pharmaceutical and other products among pharmacies.The owner of Australian pharmacy-franchise giant Chemist Warehouse is facing a public regulatory review of its plans to acquire the publicly listed Sigma Healthcare as part of a complex reverse acquisition that will see the two companies merge in a A$700 million ($463.6 million) deal....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login